omniture
logo
Search
VIVA BIOTECH HOLDINGS / PORDA HAVAS
Media Room

Latest News

rss

Focus-X Therapeutics, a Viva Biotech Portfolio Company, Successfully Reached an Acquisition Agreement with Full-Life Technologies

JERSEY CITY, N.J. and SHANGHAI, Dec. 2, 2022 /PRNewswire/ -- Focus-X Therapeutics (referred to here...

2022-12-02 18:23 3864

Portfolio Highlights: Clinical and Financial Updates of ABM, F5, AceLink, HAYA, Regenacy, and Arthrosi

SHANGHAI, Sept. 28, 2022 /PRNewswire/ -- As the investment division of Viva Biotech, Viva BioInnova...

2022-09-28 18:31 1813

Viva Biotech Announced 2022 Interim Results

Order Backlog Expected to Empower Future Growth with Increasing Long-term Competitive Advantages F...

2022-08-29 23:55 3640

Portfolio Highlights: Clinical and Financing Updates of AIxplorerBIO, Genhouse, VivaVision, Domain, Amberstone, Anji and QurAlis

SHANGHAI, China, July 27, 2022 /PRNewswire/ -- As the investment division of Viva Biotech, Viva Bio...

2022-07-27 21:30 2283
12